retatrutide regulatory status approval A review of an investigational drug retatrutide, a novel triple agonist agent for the treatment of obesity Retatrutide in Obesity and Diabetes
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2






















